MADRID — Residents of Spain’s capital ages 60 to 65 are receiving the AstraZeneca vaccine at the Wanda Metropolitan Stadium, home to the Atlético de Madrid football club.
People in that age group started getting vaccinated Tuesday ahead of residents 66 to 79 because Spain has yet to review new data provided by AstraZeneca about how its jab works in older recipients.
Spain is currently using the Pfizer/BioNTech and Moderna vaccines for people over 80.
Spanish health authorities have said they hope to speed up the rollout of vaccines with the arrival of the jab developed by the pharmaceutical company Janssen, a subsidiary of Johnson & Johnson, which has also been approved for use in Europe and requires one shot only.
Spain has so far fully vaccinated 2.6 million people, or nearly 10% of the target group of 27.4 million people that the government aims to inoculate by the end of September.
Cases are again on the rise in the country. The Health Ministry recorded Monday a cumulative incidence of 149 cases per 100,000 people over 14 days. That’s up from 129 cases per 100,000 a week ago.